Rabeprazole 20 mg EC & Domperidone 30 mg SR Capsules

Advanced Control for Acid Reflux & Nausea

ELTOSEC-DSR targets both acid secretion and gastric motility, ensuring comprehensive management of GERD, functional dyspepsia, and related symptoms.

Essential Facts

Dual-Action Composition

Structured data for ELTOSEC-DSR is captured below so regional quality, regulatory, and marketing teams can enrich or modify any empty fields.

ELTOSEC™-DSR
Generic / Molecules Rabeprazole Sodium (Enteric Coated) and Domperidone (Sustained Release) Capsules
Brand Name ELTOSEC-DSR™
Marketed By Shed No. 44, Skylin Infra Hub, B/H Intas Pharma Vasna Chacharvadi Ahmedabad Gujarat India 382213
Batch Number UC-251087B
Date of Manufacturing 12/25
Date of Expiry 11/27
Manufacturing Licence Number MNB/17/1004&MB/17/1005
MRP 115.00
Specification Enteric + sustained-release profile for acid suppression and prokinetic support

Clinical Highlights

  • Rabeprazole EC delivers rapid proton-pump inhibition for immediate symptom control.
  • Domperidone SR ensures durable prokinetic action to mitigate nausea, bloating, and reflux relapse.
  • Ideal for GERD, functional dyspepsia, and acid-related disorders that require dual-mechanism cover.